Showing 1 - 7 of 7
Persistent link: https://www.econbiz.de/10009659275
Persistent link: https://www.econbiz.de/10010370284
Persistent link: https://www.econbiz.de/10010414764
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 inhibitors, all of which are under patent protection in India. The Indian...
Persistent link: https://www.econbiz.de/10013035611
Persistent link: https://www.econbiz.de/10011640795
Persistent link: https://www.econbiz.de/10013530785